Welcome to rheumatology

Get updated – read articles and see MEDtalks

Latest news

Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases

Rheumatoid arthritis

Vaccination

September 2023 / Sofie Larsen Rasmussen

EULAR | Congress Site

May 31.- June 3. 2023

Go to page

Inflammatory joint disease: Adalimumab serum levels, anti-drug antibodies and drug survival

September 2023 / Rheumatology / Ingrid Jyssum

Stay updated here

We are on SCR 2023

We cover SCR 2023 and will give your highlights and the newests update from the congress.

Stay updated here

Articles

SCR 2023 – four days of inspiring data and interdisciplinary dialogue

August 2023 / Rheumatology / Jan Andreasen

Immunosuppressed patients with immune-mediated inflammatory diseases benefit from high post-vaccination antibody levels against COVID-19

August 2023 / Rheumatology / BestPractice Nordic

The risk of infections in neutropenic patients with SLE

August 2023 / Rheumatology / BestPractice Nordic

Researching Chronic Musculoskeletal Pain – What do Patients Think we should Prioritize?

June 2023 / Rheumatology / Kristian Damgaard Lyng / Jesper Bie Larsen / Michael Skovdal Rathleff

EULAR 2023 – UPDATE

June 2023 / Rheumatology / BestPractice Nordic

Treatment after JAK inhibitor in Patients with Rheumatoid Arthritis – What to do Next?

May 2023 / Rheumatology / Jan Andreasen

Good Practice for Developing Clinical Machine Learning Models

May 2023 / Dermatology / Simon Lebech Cichosz / Thomas Kronborg / Morten H. Jensen

Bimekizumab – Blocking of both IL-17A and IL-17F: What does it mean for us dermatologists and our patients?

May 2023 / Dermatology / Kåre Steinar Tveit

Se oversigt

Magazine

Dermatology, Gastroenterology, Rheumatology • Nr. 02 • 2023

AAD 2023: Greetings from the American Academy of Dermatology Annual Meeting
Rheumatoid Arthritis: Treatment after JAKi
Autoimmune Diseases in Children: Antibiotics May Increase the Risk

Get access

Latest MEDtalk

The MOSAIC study: Exploring apremilast’s role in psoriatic arthritis

September 2023 / Mikkel Østergaard

Psoriatic arthritis SCR23

Co-occurrence of peripheral SpA manifestations in 50% of newly diagnosed IBD patients

September 2023 / Rheumatology / Nora Vladimirova

When do patients with ANCA-associated vasculitis have highest cardiovascular risk?

September 2023 / Rheumatology / Salome Kristensen

Advancements in SLE Management

September 2023 / Rheumatology / Anders Bengtsson

Rheumatoid Arthritis – What is new from SCR23?

August 2023 / Rheumatology / Espen Haavardsholm

Management of Inflammatory Myopathy

August 2023 / Rheumatology / Ingrid Lundberg

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.

Get updated – read articles and see MEDtalks

Latest news

EULAR | Congress Site

Axial SpA – What is new?

Management of pain among patients with Psoriatic Arthritis

Hydroxychloroquine’s Role in Pregnancy for Anti-Phospholipid Antibody Patients

Cancer risk in rheumatoid arthritis patients treated with non-TNFi bDMARDs

Inflammatory joint disease: Adalimumab serum levels, anti-drug antibodies and drug survival

We are on SCR 2023

Articles

SCR 2023 – four days of inspiring data and interdisciplinary dialogue

Immunosuppressed patients with immune-mediated inflammatory diseases benefit from high post-vaccination antibody levels against COVID-19

The risk of infections in neutropenic patients with SLE

Researching Chronic Musculoskeletal Pain – What do Patients Think we should Prioritize?

EULAR 2023 – UPDATE

Treatment after JAK inhibitor in Patients with Rheumatoid Arthritis – What to do Next?

Good Practice for Developing Clinical Machine Learning Models

Bimekizumab – Blocking of both IL-17A and IL-17F: What does it mean for us dermatologists and our patients?

Magazine

Dermatology, Gastroenterology, Rheumatology • Nr. 02 • 2023

Latest MEDtalk

Co-occurrence of peripheral SpA manifestations in 50% of newly diagnosed IBD patients

When do patients with ANCA-associated vasculitis have highest cardiovascular risk?

Advancements in SLE Management

Rheumatoid Arthritis – What is new from SCR23?

Management of Inflammatory Myopathy

More from reumatology